Individualized antithrombotic therapy in acute coronary syndrome: The role of thrombin pathway inhibition and aspirin [0.03%]
急性冠脉综合征抗栓治疗的个体化选择——凝血酶通路抑制和阿司匹林的作用
Udaya Tantry,Young-Hoon Jeong,Paul A Gurbel
Udaya Tantry
Platelet-fibrin clot generation at the site of vascular injury in coronary arteries is a primary pathophysiologic event that leads to vascular occlusion and the subsequent clinical manifestations of the acute coronary syndrome (ACS). Theref...
Importance of echocardiography in patients scheduled to undergo mitral transcatheter edge-to-edge repair [0.03%]
经导管二尖瓣边对边修复术患者的超声心动图的重要性
Mesut Engin,Ufuk Aydın,Yusuf Ata et al.
Mesut Engin et al.
First-in-Poland experience with a novel lattice-tip PF/RF ablation catheter: Real-world data from a single center [0.03%]
波兰首例新型晶格尖端PF/RF导管消融导管的单中心真实世界数据体验
Piotr Gardziejczyk,Paweł Szymkiewicz,Ewa Wlazłowska-Struzik et al.
Piotr Gardziejczyk et al.
Retrospective analysis of perivascular fat in a 74-year-old man with acute coronary syndrome and zero calcium score [0.03%]
急性冠脉综合征患者回顾性分析血管周围脂肪（74岁男性，钙化积分为0）
Michał Słaboszewski,Aleksandra Woźniak,Joanna Szachowicz-Jaworska et al.
Michał Słaboszewski et al.
Long-term survival after late surgical repair of adult anomalous origin of the left coronary artery from the pulmonary artery [0.03%]
成人左冠状动脉起源于肺动脉长期生存的外科治疗效果研究
Michał Dąbrowski,Aleksandra Świeca,Magdalena Kwiatkowska et al.
Michał Dąbrowski et al.
Transcarotid transcatheter aortic valve implantation in selected patients. Authors' reply [0.03%]
经颈动脉TAVI技术的专家回信
Robert Sobczyński,Jarosław Trębacz,Paweł Kleczyński et al.
Robert Sobczyński et al.
Efficacy and safety of hybrid cardiac telerehabilitation in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction and preserved ejection fraction: The randomized clinical trial [0.03%]
非梗阻性肥厚型心肌病患者心脏远程康复的疗效和安全性：一项随机临床试验
Krzysztof Sadowski,Ryszard Piotrowicz,Mariusz Kłopotowski et al.
Krzysztof Sadowski et al.
Background: Exercise capacity is frequently reduced in patients with hypertrophic cardiomyopathy (HCM), yet structured training has historically been limited due to concerns about arrhythmias and sudden cardiac death. Rec...
Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardiooncology Task Force) and the Working Group on Cardiooncology of the Polish Cardiac Society [0.03%]
肿瘤患者心血管疾病主要预防原则（波兰心脏协会一级预防和流行病学工作组及心肿瘤学工作组专家意见）
Katarzyna Styczkiewicz,Ewa Lewicka,Agata Bielecka-Dąbrowa et al.
Katarzyna Styczkiewicz et al.
Despite spectacular progress in the treatment of patients diagnosed with cancer, cardiovascular diseases are the second leading cause of death in cancer patients, after cancer itself. According to the CONNECT-POL registry, cardiovascular ri...
Influenza vaccination as part of the cardiovascular prevention - expert opinion supported by the Working Group on Cardiovascular Pharmacotherapy and Working Group on Prevention and Epidemiology Section of the Polish Cardiac Society [0.03%]
流感疫苗作为心血管预防的一部分-由波兰心脏协会心血管药理学工作组和预防及流行病学组支持的专家意见
Marcin Wełnicki,Karol Kamiński,Agnieszka Mastalerz-Migas et al.
Marcin Wełnicki et al.
Influenza increases the risk of cardiovascular incidents, hospitalization for heart failure, heart attack, stroke and cardiovascular death. Annual influenza vaccination is a well-known, safe and effective method of reducing the risk of infe...
Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors and tafamidis treatment outcomes [0.03%]
波兰多中心转甲状腺素蛋白心肌淀粉样变患者的临床特征、基因型、心电图表现、预后预测及塔法米迪治疗效果研究
Monika Gawor-Prokopczyk,Jacek Grzybowski,Marta Lipowska et al.
Monika Gawor-Prokopczyk et al.
Background: We present the first multicenter, non-interventional, longitudinal observational study of patients diagnosed with cardiac transthyretin amyloidosis (ATTR-CA) in Poland. ...